Hygiene and wellness brand Pee Safe has partially closed its Series B round. The company has announced that it received $3 million out of the total round size of $6 million.
The funding was led by Natco Pharma Limited, a leading pharmaceutical company, and Rainmatter Health, supported by Nithin Kamath and Nikhil Kamath, founders of Zerodha. Alkemi Growth Capital, an existing investor, also participated in the round.
The Gurugram-based firm raised its pre Series B round worth around $3 million in June 2021. The fresh funds will be utilized to expand the company’s retail presence in India, expand overseas, and for marketing and awareness initiatives, Pee Safe said in a press release.
Launched in 2013 by Vikas Bagaria, and Srijana Bagaria, Pee Safe has evolved into a personal hygiene and fast-moving consumer goods (FMCG) brand. In the past six years, the company has diversified its product range to encompass various personal hygiene categories, addressing the needs of girls from puberty to menopause.
Currently, it is available in over 15,000 physical retail stores across more than 70 cities in India and maintains a strong online presence on major e-commerce platforms. As per the company, it also exports to 20 countries in 5 continents.
While Pee Safe is yet to file its FY23 results, the company claims to have achieved a growth rate of 100% CAGR over the past five years.
